Atypical antipsychotics

BRX 0.25 Pill - brown round

Generic Name: brexpiprazole

Pill with imprint BRX 0.25 is Brown, Round and has been identified as Rexulti 0.25 mg. It is supplied by Otsuka Pharmaceutical Co., Ltd. and Lundbeck.

Rexulti is used in the treatment of Major Depressive Disorder; Schizophrenia; Depression; Agitation Associated with Dementia Due to Alzheimer’s Disease and belongs to the drug class atypical antipsychotics. Rexulti 0.25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Rexulti (Brexpiprazole [ brex-pip-ra-zole ])-BRX 0.25-0.25 mg-Brown-Round
Rexulti (Brexpiprazole [ brex-pip-ra-zole ])-BRX 0.25-0.25 mg-Brown-Round

Rexulti
Generic Name: brexpiprazole [ brex-pip-ra-zole ]
Imprint: BRX 0.25
Strength: 0.25 mg
Color: Brown
Size: N/A
Shape: Round
Availability: Prescription only
Drug Class: Atypical antipsychotics
Pregnancy Category: N/A
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 59148-0035
Inactive Ingredients: Lactose monohydrate, Corn starch, Microcrystalline cellulose, Magnesium stearate, Magnesium silicate, Titanium dioxide, Ferric oxide red, Ferric oxide yellow, Ferrosoferric oxide,
Latest News
Related Drugs